NeuroQuant vs OnQ Neuro
AI Verdict
Choose NeuroQuant if…
Choose NeuroQuant if your clinical practice requires a comprehensive, automated volumetric analysis of the entire brain for a broad spectrum of neurological conditions, including neurodegenerative diseases, brain trauma, and general lesion assessment. It is particularly well-suited for longitudinal tracking of overall brain structure changes and comparisons against normative databases to aid in early diagnosis and monitoring beyond just tumors.
View NeuroQuant →Choose OnQ Neuro if…
Choose OnQ Neuro if your primary focus is on the precise, automated segmentation and volumetric quantification of brain tumors. This tool is specifically optimized for detailed tumor analysis, including tracking tumor growth or regression over multiple time points and fusing parametric maps, making it ideal for oncological diagnostics and treatment monitoring where tumor-specific metrics are critical.
View OnQ Neuro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | NeuroQuant | OnQ Neuro |
|---|---|---|
| Pricing | Subscription | Contact vendor for pricing |
| Deployment | Cloud-based; Computing appliance (local) | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | NeuroQuant | OnQ Neuro |
|---|---|---|
| Product Name | NeuroQuant | OnQ Neuro |
| Primary Focus | Automated brain MRI segmentation and volumetric analysis, aiding in the diagnosis and monitoring of neurodegenerative diseases, brain trauma, and tumors. | Automated segmentation and volumetric quantification of brain tumors on MRI, supporting clinical analysis and interpretation. |
| Company | CorTechs Labs | CorTechs Labs |
| Targeted Conditions/Analyses | Diagnosis and monitoring of neurodegenerative diseases, brain trauma, and tumors; Detection and quantification of ARIA-E and ARIA-H; Segmentation and quantification of brain lesions (T2 FLAIR hyperintense, T2* GRE/SWI hypointense). | Automatic segmentation and volumetric quantification of brain tumors. |
| Comparison Capabilities | Comparison to normative database (ages 3-100, age/gender matched); Longitudinal tracking of brain structure volumes and lesion changes over time. | Comparison of derived image metrics from multiple time-points. |
| Integration/Output | Customizable volumetric reports; Seamless integration into PACS systems. | Generates quantitative reports; Supports DICOM images. |
Videos
Demos, reviews, and walkthroughs featuring NeuroQuant and OnQ Neuro.